Ati cautat: reactii medicamente

Protocol terapeutic: L016C – : DCI INTERFERON ALFA 2B (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L008C – DCI IMATINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L002G – DCI TRATAMENT IMUNOMODULATOR – SCLEROZĂ MULTIPLĂ (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: H006C – TUMORILE NEUROENDOCRINE – TRATAMENT CU ANALOGI DE SOMATOSTATINĂ (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: H004E – DCI CETRORELIXUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: G009N – DCI SOLIFENACINUM SUCCINAT (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: G006N – DCI LUTROPINA ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: BD01D – HEMOFILIA A şi B şi BOALA VON WILLEBRAND (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B014I – DCI SULODEXIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: AE01E – DIABET ZAHARAT (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)